Syngene International Limited (SYNGENE.BO)

INR 735.45

(1.46%)

EBITDA Summary of Syngene International Limited

Syngene International Limited's latest annual EBITDA in 2023 was 10.84 Billion INR , up 7.83% from previous year.
Syngene International Limited's latest quarterly EBITDA in 2024 Q2 was 2.61 Billion INR , up 18.83% from previous quarter.
Syngene International Limited reported an annual EBITDA of 9.87 Billion INR in 2022, up 18.32% from previous year.
Syngene International Limited reported an annual EBITDA of 8.07 Billion INR in 2021, up 13.08% from previous year.
Syngene International Limited reported a quarterly EBITDA of 2.61 Billion INR for 2024 Q2, up 18.83% from previous quarter.
Syngene International Limited reported a quarterly EBITDA of 2.6 Billion INR for 2023 Q3, down -5.4% from previous quarter.

Annual EBITDA Chart of Syngene International Limited (2023 - 2009)

Historical Annual EBITDA of Syngene International Limited (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	10.84 Billion INR	7.83%
2022	9.87 Billion INR	18.32%
2021	8.07 Billion INR	13.08%
2020	7.67 Billion INR	6.46%
2019	7.66 Billion INR	14.51%
2018	6.05 Billion INR	21.43%
2017	5.26 Billion INR	6.12%
2016	4.78 Billion INR	24.46%
2015	3.86 Billion INR	32.66%
2014	2.92 Billion INR	29.12%
2013	2.59 Billion INR	31.45%
2012	2.08 Billion INR	28.23%
2011	1.38 Billion INR	57.37%
2010	1 Billion INR	-4.24%
2009	874 Million INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	1.73 Billion INR	-33.96%
2024 Q2	2.61 Billion INR	18.83%
2023 Q3	2.6 Billion INR	-5.4%
2023 Q1	2.35 Billion INR	-27.34%
2023 Q2	2.75 Billion INR	17.07%
2023 FY	- INR	7.83%
2023 Q4	3.26 Billion INR	25.35%
2022 Q4	3.24 Billion INR	30.58%
2022 FY	- INR	18.32%
2022 Q1	1.88 Billion INR	-19.63%
2022 Q2	2.31 Billion INR	23.15%
2022 Q3	2.48 Billion INR	7.03%
2021 Q2	1.9 Billion INR	7.33%
2021 FY	- INR	13.08%
2021 Q3	2.16 Billion INR	13.66%
2021 Q1	1.77 Billion INR	-34.04%
2021 Q4	2.34 Billion INR	8.32%
2020 Q3	1.93 Billion INR	14.04%
2020 FY	- INR	6.46%
2020 Q4	2.68 Billion INR	39.06%
2020 Q2	1.69 Billion INR	21.24%
2020 Q1	1.39 Billion INR	-37.0%
2019 FY	- INR	14.51%
2019 Q2	1.59 Billion INR	14.31%
2019 Q1	1.39 Billion INR	-20.11%
2019 Q4	2.21 Billion INR	27.9%
2019 Q3	1.73 Billion INR	8.57%
2018 Q4	1.75 Billion INR	10.83%
2018 FY	- INR	21.43%
2018 Q1	1.28 Billion INR	-11.94%
2018 Q2	1.44 Billion INR	12.94%
2018 Q3	1.57 Billion INR	8.97%
2017 FY	- INR	6.12%
2017 Q4	1.45 Billion INR	5.73%
2017 Q3	1.37 Billion INR	6.08%
2017 Q2	1.29 Billion INR	14.75%
2017 Q1	1.13 Billion INR	-8.93%
2016 Q3	1.27 Billion INR	4.51%
2016 Q2	1.21 Billion INR	16.43%
2016 Q1	1.04 Billion INR	-12.97%
2016 FY	- INR	24.46%
2016 Q4	1.24 Billion INR	-2.43%
2015 Q4	1.2 Billion INR	16.12%
2015 Q2	823 Million INR	2.24%
2015 Q1	805 Million INR	-5.96%
2015 Q3	1.03 Billion INR	25.88%
2015 FY	- INR	32.66%
2014 FY	- INR	29.12%
2014 Q3	786 Million INR	17.68%
2014 Q2	667.9 Million INR	16.2%
2014 Q1	574.8 Million INR	0.0%
2014 Q4	856 Million INR	8.91%
2013 FY	- INR	31.45%
2012 FY	- INR	28.23%
2011 FY	- INR	57.37%
2010 FY	- INR	-4.24%
2009 FY	- INR	0.0%

Peer EBITDA Comparison of Syngene International Limited

Name	EBITDA	EBITDA Difference
Alfavision Overseas (India) Limited	10.12 Million INR	-107041.446%
Biocon Limited	41.52 Billion INR	73.879%
Blue Jet Healthcare Limited	2.29 Billion INR	-373.193%
Concord Biotech Limited	4.65 Billion INR	-132.813%
Dishman Carbogen Amcis Limited	3.07 Billion INR	-253.115%
FERMENTA BIOTECH LIMITED	262.68 Million INR	-4029.327%
GENOMIC VALLEY BIOTECH LIMITED	147.4 Thousand INR	-7358687.533%
Lyka Labs Limited	167.58 Million INR	-6372.382%
Panacea Biotec Limited	-200.6 Million INR	5507.278%
SAMSRITA LABS LIMITED	-2.46 Million INR	440954.315%
Servoteach Industries Limited	- INR	-Infinity%
SMS Lifesciences India Limited	349.41 Million INR	-3004.376%
Supriya Lifescience Limited	1.83 Billion INR	-490.872%
TAKE Solutions Limited	-1.05 Billion INR	1132.222%
Titan Biotech Limited	360.29 Million INR	-2910.58%
Transgene Biotek Limited	-4.33 Million INR	250088.477%
Vanta Bioscience Limited	14.19 Million INR	-76335.769%